AOUT(AOUT)
AOUT
Q3 2026 EPS Estimate
$-0.24
Sep 3, 2026 · Reports after close
Revenue Estimate
$36M
FY2027E EPS$0.57
FY2028E EPS$0.80
Analyst Sentiment
Wall St. Consensus
Buy5 analysts·Limited coverage
75
Score
5 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
5100%
Hold
00%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$13.50
+19.7%
Consensus
$14.25
+26.3%
Bull
$15.00
+33.0%
12-Month Target Range5 analysts
$13.50$14.25$15.00
Current $11.28Consensus
Current Price
$11.28
Upside to Consensus
$2.97
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+6.84%
EPS+296.55%
FY2028
Rev+4.61%
EPS+39.13%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $205M | $215M |
| Low | $205M | $214M |
| High | $205M | $215M |
| EBITDA Avg | $-630,087 | $-659,111 |
| Low | $-630,433 | $-659,473 |
| High | $-629,741 | $-658,749 |
| EBIT Avg | $-15M | $-16M |
| Low | $-15M | $-16M |
| High | $-15M | $-16M |
| Net Income Avg | $7M | $10M |
| Low | $7M | $10M |
| High | $7M | $10M |
| EPS Avg | $0.57 | $0.80 |
| Low | $0.57 | $0.80 |
| High | $0.58 | $0.80 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
Quarterly
| Metric | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|
| Revenue Avg | $60M | $60M | $50M |
| Low | $59M | $59M | $49M |
| High | $60M | $61M | $51M |
| EBITDA Avg | $-183,286 | $-183,796 | $-153,344 |
| Low | $-185,639 | $-186,156 | $-155,312 |
| High | $-180,933 | $-181,437 | $-151,375 |
| EBIT Avg | $-4M | $-4M | $-4M |
| Low | $-5M | $-5M | $-4M |
| High | $-4M | $-4M | $-4M |
| Net Income Avg | $5M | $4M | $1M |
| Low | $5M | $4M | $1M |
| High | $5M | $4M | $1M |
| EPS Avg | $0.39 | $0.33 | $0.10 |
| Low | $0.38 | $0.32 | $0.10 |
| High | $0.39 | $0.34 | $0.10 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |